Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents by Zoppi, G & Trucchi, C
125
J prev med hyg 2012; 53: 125-129
Introduction. Vaccines able to prevent invasive bacterial dis-
eases have been introduced into national and/or regional immu-
nization plans through different strategies. We evaluated Haemo-
philus influenzae type b, Pneumococcus and Meningococcus C 
vaccination coverage in the 5 Ligurian Local Health Agencies, 
in the Liguria Region, and in Italy in order to assess the efficacy 
of current immunisation policies concerning children at the 24th 
month and adolescents. Furthermore, we considered new strate-
gies for increasing vaccination coverage.
Materials and methods. We estimated the vaccination coverage 
of Local Health Agency 4 by means of the “OASIS” software. 
The regional mean vaccination coverage was calculated from the 
data provided by the other four Local Health Agencies in Liguria. 
National data were obtained from the database of the Ministry of 
Health and from the last report of the ICONA Working Group. 
We used a questionnaire to evaluate the knowledge of Meningo-
coccus C vaccination among the pediatricians and general prac-
titioners operating in our Local Health Agency.
Results. The regional vaccination coverage at the 24th month 
proved to be: > 95% for Haemophilus influenzae type b, 93% 
for Pneumococcus and 87% for Meningococcus C. The national 
mean is: >95% for Haemophilus influenza type b, 55% for Pneu-
mococcus and 37% for Meningococcus C. Meningococcus C vac-
cination coverage among adolescents is 49% in Liguria, while the 
national mean is 16%. 
The questionnaire administered to the physicians was composed 
of 5 questions, which were answered by 81% of pediatricians 
and only 22% of general practitioners. Reducing the incidence 
of invasive meningococcal diseases through large-scale vaccina-
tion was deemed very important by 92% of pediatricians and 81% 
of general practitioners. About 92% of pediatricians and 85% of 
general practitioners considered the vaccine safe and effective. 
All (100%) physicians expressed their agreement with the Ligu-
rian immunization strategy. However, while all the pediatricians 
reported recommending this vaccination, only 76% of general 
practitioners did so. Finally, all the physicians interviewed stated 
their willingness to collaborate with the Department of Preven-
tion to increase vaccination coverage.
Discussion. VC against Hib at the 24th month, in both Liguria 
and Italy, proved excellent. Compliance with vaccination against 
Pneumococcus has been very high since its introduction in 2003 
in Liguria, while the national mean is suboptimal. The regional 
vaccination coverage against Meningococcus C at the 24th month 
is good; the national value, however, is low because some Ital-
ian Regions have not yet introduced this vaccination into their 
immunization plans. Vaccination coverage in adolescents varies 
widely among the Ligurian Local Health Agencies and needs to 
be increased; the national figure is very low because few Regions 
have introduced this vaccination. However, achieving compliance 
with vaccinations in adolescents is difficult. 
The questionnaire indicated that general practitioners place less 
emphasis on vaccinations than pediatricians. Nevertheless, both 
general practitioners and pediatricians expressed their willing-
ness to collaborate with the Department of Prevention of Local 
Health Agency 4 in improving the immunization strategies aimed 
at adolescents.
Conclusions. In conclusion, we consider it very important to cre-
ate a network involving the Department of Prevention, pediatri-
cians and general practitioners, in order to share the best immu-
nization strategies.
The full article is free available on www.jpmh.org
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Summary
Introduction
Many vaccines to prevent invasive bacterial diseases 
caused by Haemophilus influenzae type b (Hib), Strep-
tococcus pneumoniae and Neisseria meningitidis have 
been introduced into national and/or regional immuniza-
tion plans [1, 2]. In Italy, according to the 1999-2000 
National Immunization Program (NIP) [3], vaccination 
against Hib is recommended for newborns during the 
3rd month, followed by two further doses at the 5th and 
11th months, respectively. A hexavalent combined vac-
cine against diphtheria, tetanus, pertussis, poliomyeli-
tis, Hib and hepatitis B is now available. Vaccinations 
against Pneumococcus and Neisseria meningitidis were 
recommended at the national level in the NIP 2005-
2007 [4] for at-risk groups. In accordance with the vari-
ous regional vaccination policies, they are also offered 
to other targets. In the Ligurian schedule [5], vaccina-
tion against Streptococcus pneumoniae is recommended 
at the same age as Hib, and today we use a 13-valent 
conjugate vaccine (PCV13). Vaccination against Neis-
seria meningitidis is actively offered for 13-month-old 
infants and adolescents (15-16 years old); we usually of-
fer a Meningococcal C conjugate (MenC) vaccine [6]. 
Only the National Immunization Prevention Plan  2012-
2014, published in March 2012, recommends universal 
vaccination against Pneumococcus and Meningococcus 
C [7].
g. ZOppi, C. truCChi
126
We evaluated the vaccination coverage (VC) against the 
pathogens that cause invasive diseases in the 5 Ligurian 
Local Health Agencies (LHA), in the Liguria Region 
and in Italy, in order to verify the effectiveness of cur-
rent immunisation policies concerning children at the 
24th month and adolescents (15-16 years old). We also 
calculated the VC against diphtheria, tetanus (and per-
tussis), a well-established vaccination in adolescents, to 
compare it with MenC vaccination.  Furthermore, we 
considered new strategies for increasing vaccination 
coverage through the involvement of the pediatricians 
and general practitioners (GP) operating in the LHA 4 
district.
Materials and methods
Immunization coverage in L.H.A. 4 was calculated by 
means of the “OASIS” software (version 9.0.0). The 
Departments of Prevention of the other four Ligurian 
Regional LHA provided their data, so that we could cal-
culate the regional mean vaccination coverage. We then 
obtained national data from the database of the Ministry 
of Health and from the last report (dated 2008) of the 
ICONA Working Group, which conducted a national 
vaccination coverage survey among children and ado-
lescents [8]. 
Furthermore we elaborated a specific questionnaire 
composed of 5 questions to evaluate the knowledge and 
opinions of the MenC vaccine among the pediatricians 
and GPs operating in our LHA.
Results
Vaccination coverage
Vaccination coverage against 
Hib at the 24th month (cohort 
2008) proved to be > 95% in all 
the LHA in Liguria, which is 
comparable to the national val-
ue (Fig. 1). VC against Pneumo-
coccus at the 24th month (cohort 
2008) ranged from 86% to 95% 
in the 5 L.H.A., the regional 
mean being 93%. The national 
mean is 55%. The values con-
cerning MenC vaccination at 
the 24th month (cohort 2008) 
ranged from 78% to 92%, the 
regional and national means be-
ing 87% and 37%, respectively. 
Regarding VC against MenC in 
adolescents (cohort 1996), we 
obtained data only from 4 LHA; 
these ranged from 39% to 72% 
(Fig. 2). The regional and na-
tional means are 49% and 16%, 
respectively. The range of VC 
against diphtheria, tetanus (and 
pertussis) in Liguria is 65-75%, 
the mean being 61%; the na-
tional mean is 53%.
Fig. 1. haemophilus influenzae, pneumococcus and meningococcus C vaccination coverage 
among children aged 24 months (cohort 2008) [8].
Fig. 2. menC and dtp/dt/t vaccination coverage among adolescents (cohort 1994) [8].
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Questionnaire
The questionnaire, which was administered to all the 
pediatricians and GPs operating in our LHA (Fig. 3). 
The questionnaire was completed by 81% of pediatri-
cians and only 22% of GPs. The first question was about 
the importance of large-scale vaccination to reduce the 
incidence of invasive meningococcal diseases; 92% of 
pediatricians and 81% of GPs considered this very im-
portant. About 92% of pediatricians and 85% of GPs 
considered the vaccine to have excellent safety and 
efficacy profile. All physicians (100%) agree with the 
immunization strategy adopted by the Liguria Region, 
but only 76% of GPs tell their patients about this op-
portunity; by contrast, all the pediatricians recommend 
this vaccination. Finally, all the physicians interviewed 
stated that they were willing to collaborate with the 
Department of Prevention in raising awareness among 
subjects who do not adhere to vaccination.
Discussion
The objective of this survey was to evaluate the VC 
against the pathogens that cause invasive diseases in 
the 5 Ligurian LHA, in the Liguria Region and in It-
aly; infact immunization coverage is the best indicator 
in order to verify the efficacy of current immunisation 
policies [9] concerning children at the 24th month and 
adolescents (15-16 years old).  
The levels of VC against Hib at the 24th month, in both 
Liguria and Italy, are excellent; the objective set in the 
2005-2007 NIP has therefore been achieved. With regard 
to vaccination against Streptococcus pneumoniae, which 
was first introduced in Italy by the Liguria Region in 
2003 as a pilot study, adhesion has been very high since 
its introduction, mainly because parents perceive the se-
riousness of this invasive disease. This result is also due 
to the co-administration with the hexavalent vaccine and 
to the collaboration of pediatricians. The national mean 
is suboptimal because the various Italian Regions have 
adopted different immunization strategies. 
In Liguria, VC against MenC at the 24th month is good, 
while the ICONA 2008 report indicates that the national 
value is low [8]; this unsatisfactory national result stems 
from the fact that this vaccination has only been par-
tially introduced into regional immunization plans. VC 
levels among adolescents vary widely among the Ligu-
rian LHA, and should certainly be raised. The national 
figure is very low according to the ICONA 2008 report; 
this can be ascribed to the small number of Regions that 
have introduced this vaccination into their immunization 
Fig. 3. Questionnaire.
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plan so far. In addition, the available data on VC against 
diphtheria, tetanus (and pertussis) in adolescents indi-
cate that adhesion to vaccination is suboptimal in this 
age-group. This could be due to the lower perception 
among young people of the seriousness of infectious 
diseases and to the reduction in parents’ authority with 
regard to the healthcare choices of their children. Fur-
thermore, adolescents are treated by GPs, and no longer 
by pediatricians, who proved to be more sensitive to 
vaccination-related issues. Indeed, the responses to the 
questionnaires indicate that GPs place less emphasis on 
vaccinations, and therefore provide their patients with 
less information about the vaccination against MenC 
than pediatricians do. Nevertheless, both GPs and pedia-
tricians declared their willingness to cooperate with the 
Department of Prevention of LHA 4 in implementing 
immunization strategies addressed to adolescents.
On analyzing VC data, we can conclude that the national 
strategies which have proved helpful in achieving good 
results at the 24th month are:
the introduction of vaccinations that prevent invasive •	
diseases into regional immunization programs (ac-
tive offer and free of charge);
active calls to vaccinate all newborns against Hib and •	
Streptococcus pneumoniae; reminders for the follow-
ing vaccinations;
the inclusion of anti-Hib vaccine in the hexavalent •	
vaccine; 
co-administration of the vaccine against •	 Streptococ-
cus pneumoniae with the hexavalent vaccine;
co-administration of the vaccine against MenC with •	
the trivalent vaccine against measles, mumps and ru-
bella (MMR): high VC against MMR yields high VC 
against MenC [7];
increasing the awareness of pediatric vaccinations •	
among parents and vaccination services staff;
communication of the benefits of vaccinations by •	
pediatricians to the parents of newborns.
Effective strategies addressed to adolescents could be:
active calls to vaccination;•	
co-administration of the vaccine against MenC with •	
the diphtheria, tetanus (and pertussis) vaccine.
We also identified some critical points in the immuniza-
tion strategies specific for children up to the 24th month:
lack of vaccinations able to prevent invasive diseases •	
in some regional immunization program [10-14];
low VC against MMR determines low VC against •	
MenC;
the presence of anti-vaccination movements.•	
Other critical points in the vaccination policies addressed 
to adolescents are:
suboptimal use of the active call strategy;•	
indifference to vaccinations and infectious diseases •	
at this age;
insufficient awareness of vaccinations aimed at ado-•	
lescents and adults on the part of healthcare work-
ers;
less contact of adolescents with physicians.•	
Conclusions
This analysis indicates that various strategies could be 
adopted to improve vaccination strategies:
•	 the	application,	 in	all	Regions,	of	 the	National	 Im-
munization Prevention Plan 2012-2014, that recom-
mends universal vaccinations against Hib, Menin-
gococcus C and Pneumococcus to prevent invasive 
diseases;
•	 complete	 computerized	 information	 on	 vaccination	
services by LHA [15];
•	 systematic	use	of	the	active-call	strategy,	particularly	
with regard to adolescents;
•	 communication	 of	 VC	 data	 to	 healthcare	 workers,	
pediatricians and GPs;
•	 raising	the	awareness	of	vaccinations	aimed	at	ado-
lescents among healthcare workers;
•	 planning	 and	 promoting	 vaccination	 campaigns	
aimed at adolescents through the media, schools, 
brochures, posters;
•	 urging	pediatricians	and	GPs	to	check	their	patients’	
vaccinations certificates regularly and to actively 
recommend vaccination to those patients who have 
not been vaccinated.
Immunization strategies need to be shared with all 
healthcare workers in order to improve VC, especially 
among adolescents.  We consider it very important to 
create a network linking the Department of Prevention, 
pediatricians and GPs through regular meetings that 
highlight scientific aspects of the vaccines available and 
the epidemiology of invasive diseases.
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